These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2566505)

  • 1. Acute effects of S-adenosyl-L-methionine on catecholaminergic central function.
    Losada ME; Rubio MC
    Eur J Pharmacol; 1989 Apr; 163(2-3):353-6. PubMed ID: 2566505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute changes in 5-HT metabolism after S-adenosyl-L-methionine administration.
    Otero-Losada ME; Rubio MC
    Gen Pharmacol; 1989; 20(4):403-6. PubMed ID: 2473938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of S-adenosyl-L-methionine on the cerebral and peripheral metabolism of L-dopa].
    Bidard JN; Fonlupt P; Cronenberger L; Pacheco H
    Arch Int Physiol Biochim; 1978 Oct; 86(4):715-24. PubMed ID: 84550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-adenosyl-L-methionine improves the changes of calcium content and glucose metabolism after transient ischemia in the rat.
    Matsui Y; Yamagami I; Iwata N
    Jpn J Pharmacol; 1989 Jan; 49(1):119-24. PubMed ID: 2724673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excessive S-adenosyl-L-methionine-dependent methylation increases levels of methanol, formaldehyde and formic acid in rat brain striatal homogenates: possible role in S-adenosyl-L-methionine-induced Parkinson's disease-like disorders.
    Lee ES; Chen H; Hardman C; Simm A; Charlton C
    Life Sci; 2008 Dec; 83(25-26):821-7. PubMed ID: 18930743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further studies on catecholamine synthesis in the spontaneously hypertensive rat: catecholamine synthesis in the central nervous system.
    Yamabe H; De Jong W; Lovenberg W
    Eur J Pharmacol; 1973 Apr; 22(1):91-8. PubMed ID: 4145256
    [No Abstract]   [Full Text] [Related]  

  • 7. Depletion of S-adenosyl-L-methionine in mouse brain by antidepressive drugs.
    Taylor KM; Randall PK
    J Pharmacol Exp Ther; 1975 Aug; 194(2):303-10. PubMed ID: 1151760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia nigra degeneration and tyrosine hydroxylase depletion caused by excess S-adenosylmethionine in the rat brain. Support for an excess methylation hypothesis for parkinsonism.
    Charlton CG; Mack J
    Mol Neurobiol; 1994; 9(1-3):149-61. PubMed ID: 7888091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of central catecholamine metabolism following acute administration of ethanol.
    Liljequist S; Carlsson A
    J Pharm Pharmacol; 1978 Nov; 30(11):728-30. PubMed ID: 31442
    [No Abstract]   [Full Text] [Related]  

  • 10. Baclofen and noradrenergic function in the rat frontal cerebral cortex.
    Losada ME
    Eur J Pharmacol; 1991 May; 197(1):93-8. PubMed ID: 1909960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-adenosyl-L-methionine prevents ischemic neuronal death.
    Matsui Y; Kubo Y; Iwata N
    Eur J Pharmacol; 1987 Dec; 144(2):211-6. PubMed ID: 3436368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of S-adenosyl-L-methionine on brain muscarinic receptors of aged rats.
    Muccioli G; Scordamaglia A; Bertacco S; Di Carlo R
    Eur J Pharmacol; 1992 Nov; 227(3):293-9. PubMed ID: 1473553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the novel antidepressant S-adenosyl-methionine on alpha 1- and beta-adrenoceptors in rat brain.
    Cohen BM; Stramentinoli G; Sosa AL; Babb SM; Olgiati V
    Eur J Pharmacol; 1989 Nov; 170(3):201-7. PubMed ID: 2559855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium suppresses elevated behavioural activity and brain catecholamines in developing hyperthyroid rats.
    Rastogi RB; Singhal RL
    Can J Physiol Pharmacol; 1977 Jun; 55(3):490-5. PubMed ID: 18270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-adenosyl-L-methionine ameliorates ischemic brain metabolism in spontaneously hypertensive rats.
    Kozuka M; Iwata N
    Jpn J Pharmacol; 1989 Feb; 49(2):173-9. PubMed ID: 2733257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the brain catecholaminergic system in the regulation of dominant behavior.
    Serova LI; Naumenko EV
    Pharmacol Biochem Behav; 1996 Feb; 53(2):285-90. PubMed ID: 8808133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lead exposure on rat brain catecholaminergic neurochemistry.
    Meredith PA; McIntosh MJ; Petty MA; Reid JL
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 89(2):215-9. PubMed ID: 2898999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of scopolamine on the cerebral accumulation of 14 C-catecholamines from 14 C-tyrosine.
    Hitzemann RJ; Loh HH; Domino EF
    Pharmacology; 1972; 8(4):291-9. PubMed ID: 4657977
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of phencyclidine on the accumulation of 14 C-catecholamines formed from 14 C-tyrosine.
    Hitzemann RJ; Loh HH; Domino EF
    Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):252-8. PubMed ID: 4694363
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of mouse-killing behavior by S-adenosyl-L-methionine in midbrain raphe-lesioned and olfactory-bulbectomized rats.
    Yamamoto T; Yatsugi S; Ohno M; Ueki S
    Pharmacol Biochem Behav; 1989 Oct; 34(2):395-8. PubMed ID: 2622996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.